Abstract

Split-Course Radiotherapy for Poor-Risk Stage III Lung Cancer: Striking the Right Balance or History Regurgitated?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Sound and Fury About Postoperative Therapy for Lung Cancer
Andrew T Turrisi
Mayo Clinic Proceedings | VOL. 67
Andrew T TurrisiAndrew T Turrisi
01 Dec 1992
Split-Course Versus Continuous Thoracic Radiation Therapy for Limited-Stage Small-Cell Lung Cancer: Final Report of a Randomized Phase III Trial
A William Blackstock ... Antonius A Miller
Clinical lung cancer | VOL. 6
A William Blackstock, et. al.A William Blackstock ... Antonius A Miller
01 Apr 2005
Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer. A radiologic and physiologic study.
K Mattson ... M Salmo
Acta Oncologica | VOL. 26
K Mattson, et. al.K Mattson ... M Salmo
01 Jan 1987
İleri Küçük Hücreli Olmayan Akciğer Kanserinde Split Kurs Radyasyon Tedavisi Alan Hastalarda Fiziksel Akciğer Doz-Hacim Parametrelerinin Değerlendirilmesi: Analitik Araştırma, Vaka-Kontrol
Esin Gündem ... Yelda Elçi̇m
Turkiye Klinikleri Journal of Medical Sciences | VOL. 42
Esin Gündem, et. al.Esin Gündem ... Yelda Elçi̇m
01 Jan 2021
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
PP01.99 Switching to Subcutaneous (SC) Atezolizumab After Intravenous (IV) Dosing: Evaluation of Atezolizumab Pharmacokinetics (PK) Using Population PK Modeling
Stephanie N Liu ... Benjamin Wu
Journal of Thoracic Oncology | VOL. 19
Stephanie N Liu, et. al.Stephanie N Liu ... Benjamin Wu
01 Jul 2024
View more papers